Dr. Che-Ming Jack Hu is an assistant research fellow at the Institute of Biomedical Sciences at Academia Sinica, Taiwan. Dr Hu received his PhD in Bioengineering in December 2011 from UCSD and holds a Bachelors in Bioengineering from UC Berkeley. His research focus is on nanotechnology, drug delivery, biodetoxification, and vaccine development. Dr. Hu is the inventor of cell-membrane cloaked nanoparticles, which is an innovative biomimetic platform with significant implications in nanomedicine. The technology is highlighted in multiple high-impact publications including Proceedings of Nature, National Academy of Sciences, Nature Nanotechnology. The technology has also led to a spinoff company, Arytha Biosciences which focuses on the translation of the nanoparticle platform.